Cybin Inc. is trading at $4.28 (+5.68%) as the stock gains momentum following a broader market recovery.
- Major U.S. indexes are trading higher, providing support for speculative and small-cap biotech stocks after several consecutive down sessions.
- No fresh company-specific catalysts have been identified, indicating the current price action is primarily market-driven rather than news-driven.